1. Signaling Pathways
  2. MAPK/ERK Pathway
  3. MAP3K


MAP3Ks (Mitogen-activated protein kinase kinase kinases), the top components of MAPK cascades, modulate many biological processes, such as growth, development and various environmental stresses. Based on the sequence of their kinase catalytic domain, MAP3Ks are classified into three groups: the MEKK-like, ZIK-like and Raf-like families. Raf-like MAP3Ks constitute largest MAP3K subfamily. Raf-like MAP3Ks play roles in response to biotic and abiotic stresses.

MAP3Ks often bind to both MAP4Ks and MAP2Ks in the same pathway. For example, MEKK1 (MAP3K1) binds to both the MAP4K NIK and the MAP2K MKK4, while NSY-1 (MAP3K) binds to the MAP2K SEK-1. MAP3Ks activates MAP2Ks by phosphorylation of a serine and/or threonine, and MAP2Ks activate MAPKs by dual phosphorylation of a Thr-X-Tyr motif.

MAP3K Isoform Specific Products:

  • MAP3K5/ASK1

  • MAP3K7/TAK1

  • MAP3K8

MAP3K 相关产品 (5):

Cat. No. Product Name Effect Purity
  • HY-12686
    5Z-7-Oxozeaenol Inhibitor >99.0%
    5Z-7-Oxozeaneol 是一种天然的抗原生动物化合物,为有效的,不可逆的,选择性的 TAK1VEGF-R2 抑制剂,IC50 值分别为 8 nM 和 52 nM。
  • HY-32018
    Cot inhibitor-2 Inhibitor 99.22%
    Cot inhibitor-2 是一种有效的,选择性的,具有口服活性的 cot (Tpl2/MAP3K8) 抑制剂,IC50 为 1.6 nM。Cot inhibitor-2 抑制 LPS 刺激的人全血中 TNF-α 的产生,IC50 为 0.3 μM。
  • HY-12358
    Tpl2 Kinase Inhibitor 1 Inhibitor >99.0%
    Tpl2 Kinase Inhibitor 1 (Compound 1) 是一种有效的选择性 Tpl2 (COT 激酶,MAP3K8) 抑制剂,可用于炎症反应和某些癌症的研究。
  • HY-32015
    Cot inhibitor-1 Inhibitor 98.13%
    Cot inhibitor-1 (compound 28) 是一种选择性的Tpl2 kinase抑制剂,IC50 为 28 nM。Cot inhibitor-1 对人全血中 TNF-alpha 的产生具有抑制作用,IC50 为 5.7 nM。
  • HY-103258
    TC ASK 10 Inhibitor 99.84%
    TC ASK 10 (Compound 10) 是一种有效的,选择性的,口服活性的细胞凋亡信号调节激酶 1 (ASK1) 抑制剂,IC50 为 14 nM。TC ASK 10 对其他代表性激酶的抑制活性低于 50%,ASK2 除外 (IC50 为 0.51 μM)。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.